                               SEQUENCE LISTING

<110> MEDIMMUNE, LLC
 
<120> METHODS OF CELL SELECTION

<130> NNAA-300-WO-PCT

<140> PCT/US2019/049745
<141> 2019-09-05

<150> 62/728,186
<151> 2018-09-07

<160> 4     

<170> PatentIn version 3.5

<210> 1
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 1
Gly Leu Asn Asp Ile Phe Glu Ala Gln Lys Ile Glu Trp His Glu 
1               5                   10                  15  


<210> 2
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 2
Thr Glu Thr Ser Gln Val Ala Pro Ala 
1               5                   


<210> 3
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 3
Gly Gly Ser Gly Gly Ser Gly Gly Ser Gly Gly Ser Gly Gly 
1               5                   10                  


<210> 4
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 4
Asp Tyr Asp Asp Asp Asp Lys 
1               5           


